InvestorsHub Logo
Followers 1
Posts 681
Boards Moderated 0
Alias Born 06/20/2019

Re: None

Monday, 12/09/2019 2:27:57 PM

Monday, December 09, 2019 2:27:57 PM

Post# of 11958
Orgenesis just announced its JV is up and running in Greece.

https://www.hygeia.gr/en/press-release/partnership-agreement-between-hygeia-group-and-the-theracell-orgenesis-joint-venture-in-the-area-of-advanced-cell-and-gene-therapy/

Now what the hell does that have to do with anything you ask? Because this was mentioned on 2-14-19 in their 10Q as the "Greek JVA". It took them 10 months to get it up and running.

The JV with Kinerjapay was mentioned on 5-6-19. It's not surprising we haven't heard anything yet. My guess is, same time frame. We may not hear anything until March regarding this.

I think it all has the do with the funding MaSThercell Global gets from Great Point Partners. They got an initial 11.8 Mil up front, and then had to meet revenue and EBITDA targets to receive more funding. The total funding was 25 mil. The JV with Kinerjapay required 5 mil within 3 years from each company.

Don't know if they'll go in order of the 10Q, but the "Panama JVA" is next. From 3-12-19. Then the "Singapore JVA" which is Kinerjapay.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.